TOP STORIES

• REGULATORY KM Biologics’s Smallpox Vaccine in Line to Add Monkeypox Use
  August 1, 2022

• REGULATORY New Expert Panel to Issue Proposals for 2023, 2024 Price Revisions; Official Spearheading Debate Prods Industry to Speak Up
  July 29, 2022

• BUSINESS Takeda to Lift Restricted Shipments for Leuplin in September after Over 2 Years
  July 29, 2022

• BUSINESS Mochida to Quit Filgrastim Biosimilar as Repeated Price Cuts Made It Unprofitable
  July 28, 2022

• BUSINESS GSK Japan Foresees 5% Annual Growth by 2026: President Lirette
  July 28, 2022

• BUSINESS Horizon Japan Eager for Solo Sales of Its 1st Product as Tepezza Trial Likely to Wrap Up Next Year
  July 27, 2022

• ORGANIZATION Veterans’ Group Proposes Timely Drug Re-Pricing with Online Data, Reimbursement at Actual Purchase Prices
  July 27, 2022

• ORGANIZATION JPMA Delays Announcement of Drug Pricing Proposal
  July 27, 2022

• BUSINESS BMS Has High Hopes on Eliquis Follow-Up with Less Bleeding Risks as Patent Loss Looms
  July 26, 2022

• REGULATORY Japan Confirms 1st Monkeypox Case
  July 26, 2022

• COMMENTARY Govt Should Examine Challenges with Emergency Approval Scheme Exposed by Shionogi Pill Review
  July 25, 2022

• REGULATORY KM Biologics’s Smallpox Vaccine Up for Review for Monkeypox Use
  July 25, 2022

• BUSINESS Keytruda, Opdivo, Tagrisso Breach 100 Billion Yen Sales Mark in FY2021: Tally
  July 22, 2022

• BUSINESS Shionogi to Steadily Promote PIII Trial for COVID Pill after Approval Setback
  July 22, 2022

• REGULATORY Japan Again Takes Pass on Emergency Approval for Shionogi’s COVID Pill as Panels Nix Presumed Efficacy
  July 21, 2022

• REGULATORY MHLW Official Sees More “Specified Clinical Research” Data Used in Regulatory Submissions to Fill Industry-Academia Void
  July 20, 2022

• REGULATORY MHLW Eyes Expert Panel Launch This Summer for Drug Distribution and Pricing: Official
  July 19, 2022

• REGULATORY Japan Plans to Lower Minimum Age for Novavax Jab to 12
  July 19, 2022

• ORGANIZATION Savings from Off-Year Drug Re-Pricing Should Go Towards Medical Fees: JMA Chief
  July 15, 2022

• BUSINESS Pfizer Japan Files COVID-19 Vaccine for Ages 6 Months to 4 Years
  July 15, 2022

ページ

• « 先頭
• ‹ Prev
• …
• 68
• 69
• 70
• 71
• 72
• 73
• 74
• 75
• 76
• …
• Next ›
• 最終 »